Viking Therapeutics Inc
NASDAQ:VKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
A
|
Axon Enterprise Inc
XMUN:TCS
|
US |
|
Alphabet Inc
MIL:1GOOG
|
US |
|
COL Digital Publishing Group Co Ltd
SZSE:300364
|
CN |
|
C
|
CoreWeave Inc
NASDAQ:CRWV
|
US |
|
S
|
Secom Co Ltd
SWB:XSC
|
JP |
|
Honeywell International Inc
NASDAQ:HON
|
US |
|
JMDC Inc
F:6JM
|
JP |
|
Koninklijke Ahold Delhaize NV
F:AHOG
|
NL |
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
DE |
|
Iberdrola SA
F:IBE1
|
ES |
|
M
|
Macy's Inc
SWB:FDO
|
US |
|
Frontier Group Holdings Inc
F:0VN
|
US |
|
A
|
ASML Holding NV
F:ASME
|
NL |
|
Hankyu Hanshin Holdings Inc
TSE:9042
|
JP |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AIL
|
FR |
Bankruptcy Probability
Viking Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Viking Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Viking Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Viking Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.